References
- Jeong HK, Lee KH, Kim MH, Kim SH, Kim MG, Kim HC. Signal Intensity of Contrast Enhancement according to TE in 3.0T MRI T1 Imaging. Journal of Applied Science. 2018;8(7): 1138. https://doi.org/10.3390/app8071138
- Kim SH, Kwon SY, Kang CH, Jeong HK, Kim SW, Park YJ, Han DK, Hong JW, Heo YC. Analysis of Peak Velocity and Mean Velocity According to Shimming Technique in 2D Phase Contrast : Comparison of 1.5T Tesla and 3.0 Tesla. Journal of Magnetics. 2018;23(2):201-6. https://doi.org/10.4283/JMAG.2018.23.2.201
- E. Hagberg, K. Scheffler. Effect of r(1) and r(2) relaxivity of gadolinium-based contrast agents on the T1-weighted MR signal at increasing magnetic field strengths. Contrast Media Mol Imaging. 2013;8(6):456-65. https://doi.org/10.1002/cmmi.1565
- Z. Seidl, J. Vymazal, M. Mechl, M. Goyal, M. Herman, C. Colosimo, M. Pasowicz, R. Yeung, B. Paraniak-Gieszczyk, B. Yemen, N. Anzalone, A. Citterio, G. Schneider, S. Bastianello, J. Ruscalleda. Does higher gadolinium concentration play a role in the morphologic assessment of brain tumors? Results of a multicenter intraindividual crossover comparison of gadobutrol versus gadobenate dimeglumine (the MERIT Study). AJN-RAmJNeuroradiol. 2012;33(6):1050-8.
- Bloembergen N, Purcell EM, Pound RV. Relaxation effects in nuclear magnetic resonance absorption. Phys Rev. 1948;73:679. https://doi.org/10.1103/PhysRev.73.679
- Bloembergen N. Proton relaxation times in paramagnetic solution. J Chem Phys. 1957;27:572. https://doi.org/10.1063/1.1743771
- Just M, Thelen M. Tissue characterization with t1, t2, and proton density values: results in 160 patients with brain tumors. Radiology. 1988;169(3):779-785. https://doi.org/10.1148/radiology.169.3.3187000
- Maravilla KR, Smith MP, Vymazal J, Goyal M, Herman M, Baima JJ, Babbel R, Vaneckova M, Zizka J, Colosimo C, Urbanczyk-Zawadzka M, Mechl M, Bag AK, Bastianello S, Bueltmann, E, Hirai T, Frattini T, Kirchin MA, Pirovano G. Are there differences between macrocyclic gadolinium contrast agents for brain tumor imaging? Results of a multicenter intraindividual crossover comparison of gadobutrol with gadoteridol (the TRUTH study). AJNR Am J Neuroradiol 2015;36:14-23. https://doi.org/10.3174/ajnr.A4154
- Maravilla KR, San-Juan D, Kim SJ, Elizondo-Riojas G, Fink JR, Escobar W, Bag A, Roberts DR, Hao J, Pitrou C, Tsiouris AJ, Herskovits E, Fiebach JB. Comparison of gadoterate meglumine and gadobutrol in the MRI diagnosis of primary brain tumors: A double-blind randomized controlled intraindividual crossover study (the REMIND study). AJNR Am J Neuroradiol 2017;38:1681-8. https://doi.org/10.3174/ajnr.A5316
- Shen WC, Cheng TY, Lee SK, Ho YJ, Lee KR. Disseminated tuberculomas in spinal cord and brain demonstrated by MRI with gadolinium-DTPA. Neuroradiology. 1993;35:213-5. https://doi.org/10.1007/BF00588498
- Owen NJ, Sohaib SA, Peppercorn PD, Monson JP, Grossman AB, Besser GM, Reznek RH. MRI of pancreatic neuroendocrine tumours. Br J Radiol. 2001;74:968-73. https://doi.org/10.1259/bjr.74.886.740968
- van Walderveen MAA, Barkhof F, Hommes OR, Polman CH, Tobi H, Frequin ST, Valk J. Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images. Neurology. 1995;45:1684-90. https://doi.org/10.1212/WNL.45.9.1684
- Rajan T. Gupta, Daniele Marin, Daniel T. Boll, Daniela B. Husarik, Drew E. Davis, Sebastian Feuerlein. Hepatic hemangiomas: Difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium. European journal of Radiology. 2012;81(10):2457-62. https://doi.org/10.1016/j.ejrad.2011.10.014
- Jeong HK, Kim MK, Nam KC, Jung HD, Ahn CG, Kim HC. Optimal Echo Phase of FLASH sequence for Brain Enhancement scan of mouse at 9.4T MRI system. Journal of IEIE. 2017;54(7):115-24. https://doi.org/10.5573/ieie.2017.54.10.115